Skip to main content
VCbacked
Log inGet Started

Indapta Therapeutics

San Francisco, United States

Indapta Therapeutics is a privately held biotechnology company.

$50.8M raised
Oct 2025
Venture - Series Unknown
BiopharmaBiotechnologyMedical

Top Investors

RA Capital ManagementVertex VenturesLonzaCancer Prevention and Research Institute of TexasPontifax

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Indapta Therapeutics

How much funding has Indapta Therapeutics raised?
Indapta Therapeutics has raised $50.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Who are Indapta Therapeutics's investors?
Indapta Therapeutics's investors include RA Capital Management, Vertex Ventures, Lonza, Cancer Prevention and Research Institute of Texas, Pontifax.
Where is Indapta Therapeutics headquartered?
Indapta Therapeutics is headquartered in San Francisco, United States.
What does Indapta Therapeutics do?
Indapta Therapeutics is a privately held biotechnology company.
What stage is Indapta Therapeutics at?
Indapta Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Indapta Therapeutics — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/indapta-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Indapta Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/indapta-therapeutics
Wikipedia (cite web)
{{cite web |title=Indapta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/indapta-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego